TRF2 Overexpression at the Surgical Resection Margin: A Potential Predictive Biomarker in Oral Squamous Cell Carcinoma for Recurrence
- PMID: 33994727
- PMCID: PMC8119552
- DOI: 10.1007/s13193-020-01042-5
TRF2 Overexpression at the Surgical Resection Margin: A Potential Predictive Biomarker in Oral Squamous Cell Carcinoma for Recurrence
Abstract
Oral squamous cell carcinoma (OSCC) is one of the most prevalent cancers in India with high incidence rate in eastern region due to habits of tobacco, pan and gutkha chewing habits. In majority of OSCC, the cases were presented to clinicians at later stages of the disease which leads to increased mortality. In addition presence of minimal residual disease also significantly contributed towards disease progression. Therefore, identification of potential biomarker for prognostic stratification of patients with high risk of disease recurrence and appropriate management is utmost necessary. In this study, 80 OSCC patients were included and their tumour specimen along with cut margin (CM) was collected after surgical excision. Immunohistochemistry (IHC) was performed to check expression of TRF2 in tumour and CM of OSCC patients. Statistical analysis was carried out using SPSS based on clinical and pathological records. It was observed that 27 OSCC patients developed recurrence during the period of the study (2012-2016). It was observed that, in 34 cases (42.25%) TRF2 expression was positive in tumour, while in 46 cases (57.75%), it was negative, while it was just reverse at CM, respectively. The odds of recurrence among patients having high levels of TRF2 in CM were 2.6 times higher than the odds of recurrence among patients having lower levels of TRF2 in CM. In conclusion, this study showed that TRF2 at surgical cut margin has a prognostic significance and can be used as a molecular marker for predicting survival in OSCC patients.
Keywords: Oral squamous cell carcinoma (OSCC); Prognostic marker; Recurrence; TRF2.
© Indian Association of Surgical Oncology 2020.
Conflict of interest statement
Conflict of InterestThe authors declare that they have no conflict of interest.
Figures


Similar articles
-
𝛽-Catenin-a Possible Prognostic Molecular Marker for Recurrence in Histopathologically Negative Surgical Margin of Oral Cancer.Indian J Surg Oncol. 2021 Apr;12(Suppl 1):128-133. doi: 10.1007/s13193-020-01217-0. Epub 2020 Oct 11. Indian J Surg Oncol. 2021. PMID: 33994738 Free PMC article.
-
Role of Telomeric TRF2 in Orosphere Formation and CSC Phenotype Maintenance Through Efficient DNA Repair Pathway and its Correlation with Recurrence in OSCC.Stem Cell Rev Rep. 2018 Dec;14(6):871-887. doi: 10.1007/s12015-018-9823-z. Stem Cell Rev Rep. 2018. PMID: 29872959
-
Surgical tumour margins and their significance in oral squamous cell carcinoma.J Oral Pathol Med. 2022 Apr;51(4):311-314. doi: 10.1111/jop.13276. Epub 2022 Feb 8. J Oral Pathol Med. 2022. PMID: 35080080 Review.
-
[Application of near infrared fluorescence imaging in detection of residual cancer in oral squamous cell carcinoma].Zhonghua Zhong Liu Za Zhi. 2022 May 23;44(5):450-454. doi: 10.3760/cma.j.cn112152-20200619-00579. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35615804 Chinese.
-
Impact of surgical resection margins less than 5 mm in oral cavity squamous cell carcinoma: a systematic review.Acta Otolaryngol. 2020 Oct;140(10):869-875. doi: 10.1080/00016489.2020.1773532. Epub 2020 Jun 21. Acta Otolaryngol. 2020. PMID: 32564643
Cited by
-
Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells.Acta Pharmacol Sin. 2024 Jun;45(6):1276-1286. doi: 10.1038/s41401-024-01243-6. Epub 2024 Mar 4. Acta Pharmacol Sin. 2024. PMID: 38438580 Free PMC article.
References
-
- Sproll C, Fluegen G, Stoecklein NH (2018) Minimal Residual Disease in Head and Neck Cancer and Esophageal Cancer, in Biological Mechanisms of Minimal Residual Disease and Systemic Cancer, J.A. Aguirre-Ghiso, Editor, Springer International Publishing: Cham p 55-82 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous